Y-mAbs Therapeutics
YMAB
#7268
Rank
A$0.58 B
Marketcap
$13.07
Share price
0.49%
Change (1 day)
19.81%
Change (1 year)

Earnings for Y-mAbs Therapeutics (YMAB)

Earnings in 2024 (TTM): -A$42.31 Million

According to Y-mAbs Therapeutics 's latest financial reports the company's current earnings are A$84.55 Million. In 2023 the company made an earning of -A$41.18 Million, an increase over its 2022 earnings that were of -A$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Y-mAbs Therapeutics from 2018 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -A$42.31 Million2.75%
2023 -A$41.18 Million-72.92%
2022 -A$0.16 Billion77.47%
2021 -A$85.69 Million-55.46%
2020 -A$0.2 Billion44.49%
2019 -A$0.14 Billion92.01%
2018 -A$69.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.22 Billion 373.42%๐Ÿ‡บ๐Ÿ‡ธ USA